Enhancement of cerebral blood flow by hypoxia is critical for brain function, but signaling systems underlying its regulation have been unclear. We report a pathway mediating hypoxia-induced cerebral vasodilation in studies monitoring vascular disposition in cerebellar slices and in intact mouse brains using two-photon intravital laser scanning microscopy. In this cascade, hypoxia elicits cerebral vasodilation via the coordinate actions of H 2 S formed by cystathionine β-synthase (CBS) and CO generated by heme oxygenase (HO)-2. Hypoxia diminishes CO generation by HO-2, an oxygen sensor. The constitutive CO physiologically inhibits CBS, and hypoxia leads to increased levels of H 2 S that mediate the vasodilation of precapillary arterioles. Mice with targeted deletion of HO-2 or CBS display impaired vascular responses to hypoxia. Thus, in intact adult brain cerebral cortex of HO-2-null mice, imaging mass spectrometry reveals an impaired ability to maintain ATP levels on hypoxia.
Enhancement of cerebral blood flow by hypoxia is critical for brain function, but signaling systems underlying its regulation have been unclear. We report a pathway mediating hypoxia-induced cerebral vasodilation in studies monitoring vascular disposition in cerebellar slices and in intact mouse brains using two-photon intravital laser scanning microscopy. In this cascade, hypoxia elicits cerebral vasodilation via the coordinate actions of H 2 S formed by cystathionine β-synthase (CBS) and CO generated by heme oxygenase (HO)-2. Hypoxia diminishes CO generation by HO-2, an oxygen sensor. The constitutive CO physiologically inhibits CBS, and hypoxia leads to increased levels of H 2 S that mediate the vasodilation of precapillary arterioles. Mice with targeted deletion of HO-2 or CBS display impaired vascular responses to hypoxia. Thus, in intact adult brain cerebral cortex of HO-2-null mice, imaging mass spectrometry reveals an impaired ability to maintain ATP levels on hypoxia.
gas biology | neurovascular unit | energy metabolism | gasotransmitter T he cerebral circulation is maintained by autoregulation, which prevents marked alterations in response to changes in blood pressure, whereas functional hyperemia links blood flow to neural activity (1) . Blood flow regulation in the brain is modulated by O 2 (2) , with increased cerebral blood flow in response to hypoxia critical for protecting the brain against diverse insults. Such regulation also participates in functional hyperemia, as demonstrated by functional MRI investigations indicating a transient decrease in O 2 levels preceding activation of blood flow in response to neuronal firing (3).
Alterations in cerebral blood flow in response to hypoxia and neural activity are mediated via several neurotransmitter systems, with prominent involvement of the gaseous mediator nitric oxide (NO) (1, 2) . In response to glutamate acting on NMDA receptors, neuronal NO synthase (nNOS) is activated by increases in intracellular calcium, with the generated NO stimulating soluble guanylyl cyclase, thereby increasing cGMP levels to dilate blood vessels (4) . Functional hyperemia is decreased by ∼50% in rats in response to inhibition of nNOS (5) . Another gaseous mediator, CO (6) (7) (8) , is also vasoactive. In some blood vessel systems (e.g., liver sinusoids), CO causes vasodilation, and inhibition of its biosynthetic enzyme HO-2 leads to vasoconstriction (9) (10) (11) (12) (13) . However, in the cerebral circulation, CO elicits vasoconstriction. Thus, HO inhibitors cause cerebral vasodilation, an effect reversed by CO (14) . This action of CO cannot be readily explained by previously identified CO receptors, such as soluble guanylyl cyclase (6) (7) (8) (9) (10) (11) (12) 15) or potassium channels (13, 16) , both of which mediate vasodilation. The CO and NO systems interface; thus, the vasodilatory actions of HO inhibitors are partially reversed by inhibitors of NOS (14) . A third gaseous mediator, H 2 S, is also vasoactive, eliciting vasodilation in both the peripheral and cerebral circulation (17) (18) (19) (20) (21) . H 2 S can be physiologically generated by two enzymes, cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE). In peripheral blood vessels, CSE is localized to the endothelium, and endothelial-derived relaxing factor activity in peripheral vessels is reduced by ∼75% in CSE-null mice (18) . H 2 S exerts its physiological actions by covalently modifying the sulfhydryl group of cysteines in target proteins in a process termed S-sulfhydration, which is analogous to S-nitrosylation by NO (22) (23) (24) (25) . The vasodilating actions of H 2 S are associated with sulfhydration of a specific cysteine in ATP-sensitive potassium (K ATP ) channels of blood vessels, activating the channels and hyperpolarizing the vascular endothelial and smooth muscle cells (25) .
The brain generates micromolar amounts of CO via HO-catalyzed reactions using O 2 as a substrate, with HO-2 accounting for ∼80% of the total rodent brain HO activity (14, 26) . A recent metabolomic study in murine liver using capillary electrophoresis-mass spectrometry (CE-MS) identified CBS as a CO sensor regulating bicarbonate-dependent biliary choleresis (27) . CBS is a hemethiolate enzyme (28) that catalyzes multiple H 2 S-generating reactions (29, 30) . The prosthetic heme of this enzyme (31-33) allows the reversible coordinate bonding of gaseous ligands, such as CO and NO (34). Interestingly, CO, but not NO, inhibits the activity of CBS in vitro (31, 32) and in vivo (27) , making CBS a CO-specific sensor.
In the present study, we show that hypoxia-induced arteriolar vasodilation in brain slices and intact mice is mediated via a signaling system in which HO-2 is the O 2 sensor. HO-2 uses O 2 to generate CO, which tonically inhibits the ability of astrocytic CBS, a CO-specific sensor (27, 31, 32) , to generate vasodilatory H 2 S (17-21). During hypoxia, inhibition of HO-2-mediated CO production occurs, with a corresponding release of the tonic inhibition of CBS, allowing it to generate H 2 S, which in turn elicits arteriolar vasodilation.
Results
Neuronal and Endothelial Localization of HO-2 and Glial Localization of CBS. Because CBS accounts for the great bulk of H 2 S generation in the brain (35), and because its heme group provides a CO-sensing mechanism (27, 31, 32) , we compared the localizations of CBS in the brain with those of HO-2, the main CO-producing isozyme in the brain (14) . Immunohistochemical analysis in the neonatal mouse cerebellum revealed expression of HO-2 in neurons and endothelial cells ( Fig. 1 A-D) . In contrast, CBS was expressed in Bergmann glia and astrocytes ( Fig. 1 E-H) . Consistent with these observed CBS localizations, generation of H 2 S was abolished in primary astrocytic cultures from CBS-null mice (Fig. S1) . Moreover, metabolomic analysis using CE-MS revealed that levels of cystathionine, another CBS product, were below the limit of detection in primary astrocytic cultures from CBS-null mice (Fig. S1C) . In the cortex, CBS appears to be the main H 2 Sproducing enzyme, given that expression of CSE, another H 2 Sproducing enzyme, is limited to vascular smooth muscle cells surrounding large vessels in the subarachnoid space and in specific neurons in striatum and hippocampus (Fig. S2) . Pericytes, key effector contractile cells (36) surrounded by HO-2-containing endothelia and CBS-containing astrocytic endfeet that physically link neurons to the vasculature, compose a neurovascular unit with optimal spatial localizations for multiple gaseous molecular signals to control microvascular resistance (Fig. 1I ).
HO-2/CO Cerebral Vasoconstrictor Tone Is CBS-Dependent. It was previously shown that HO inhibitors cause vasodilation in the pial microcirculation, suggesting that CO is responsible for a cerebral vasoconstrictor tone (14) . We confirm these findings, showing that the HO inhibitors zinc protoporphyrin-IX (ZnPP; 1 μM) and chromium (III) mesoporphyrin-IX (CrMP; 1 μM) dilated arterioles in cerebellar slices by ∼50% at 60 min (Fig. 2) . In contrast, copper protoporphyrin-IX, an analog that does not inhibit HO, had no effect. Tricarbonyldichlororuthenium(II) dimer, [Ru (CO) 3 Cl 2 ] 2 , a CO-releasing molecule (CORM-2; 100 μM) (37), reversed the effect of ZnPP (Fig. 2C) , confirming that CO is a tonic vasoconstrictor under basal conditions. This action of CO cannot be readily explained by previously identified CO receptors, such as soluble guanylyl cyclase (6) (7) (8) (9) (10) (11) (12) 15) or potassium channels (13, 16) , both of which mediate vasodilation. Based on previous studies indicating that physiological concentrations of CO can inhibit the ability of CBS to generate vasodilatory H 2 S (17-21, 26, 27, 38), we hypothesize that endogenous CO serves as a tonic vasoconstrictor by inhibiting CBS, thus preventing the H 2 S-mediated vasodilatory response. The H 2 S donor sodium hydrosulfide (NaHS; 30 μM) elicits comparable vasodilation to that provided by ZnPP. In CBS-null mice, whose astrocytes lose the ability to produce H 2 S (Fig. S1B) , inhibition of endogenous CO production by ZnPP did not cause vasodilation (Fig. 2C ). On the other hand, NaHS induced substantially greater vasodilation in CBS-null mice than in WT mice (Fig. 2C ), indicating that the vasodilatory machinery in CBS-null mice is intact + cells along the vessel wall in B are endothelial, not pericytic, because nuclei of cells positive for NG2 (a pericytic marker) stained with TO-PRO-3 (TOPRO, a nucleic acid stain), are completely devoid of CD31 (endothelial marker) labeling in C. In D, the arteriolar wall is surrounded by NG2 + pericytes, important contractile cells within the neurovascular unit. (E-H) CBS, an H 2 S-producing enzyme, is concentrated at the ascending processes of Bergmann glia (arrow in E and F) and radial processes of astrocytes (arrowheads in E and G), as evidenced by the colocalization with GFAP, an established marker of glial cells. The astrocytic endfeet in contact with the vessel wall are CBS-positive in H. ml, molecular layer; Pl, Purkinje cell layer; gl, granular layer; e, endothelium; p, pericyte. (I) Schematic depiction of localization of HO-2 and CBS in the neurovascular unit. Vasodilation induced by HO inhibition is reversed by tricarbonyldichlororuthenium(II) dimer, [Ru(CO) 3 Cl 2 ] 2 , a CO-releasing molecule (CORM-2; 100 μM), indicating that CO acts as a tonic vasoconstrictor. The vasodilatory response of ZnPP does not occur in CBS-null slices. Glib, glibenclimide, an inhibitor of K ATP channels. *P < 0.05 compared with the vehicle-treated control; † P < 0.05 compared with the ZnPP-treated WT mice; ‡ P < 0.05 compared with the ZnPP-treated WT mice. Values are mean ± SEM. and appears to display supersensitivity of H 2 S-responsive elements after depletion of endogenous H 2 S. Physiological vasodilation elicited by H 2 S is mediated by K ATP channels (21) , the blockade of which by glibenclamide (100 μM) abolishes the effects of NaHS. Glibenclamide was seen to abolish CrMP-induced arteriolar vasodilation (Fig. S3 ). These findings suggest that cerebral vessels are regulated by a signaling cascade in which CO formed by HO-2 residing in the endothelia and/or neurons basally inhibits H 2 S production from glial CBS.
HO-2/CO and CBS/H 2 S Pathways Mediate Hypoxia-Induced Arteriolar Vasodilation. The coordinate actions of HO-2 and CBS might form a signaling system that mediates hypoxia-induced arteriolar vasodilation. Hypoxia inhibits oxidative phosphorylation, as well as the activities of various enzymes that use molecular O 2 as a substrate. HO-2 is such an enzyme, which functions as an O 2 sensor in the carotid body (39, 40). We wondered whether the vasodilation observed on hypoxia reflects a decrease in HO-2-derived CO, diminishing the inhibition of CBS and leading to an increase in CBS-derived H 2 S with resulting vasodilation. In this model, HO-2 serves as the O 2 sensor, modulating its generation of CO in proportion to O 2 levels. To test this hypothesis, we examined how the deletion of HO-2 or CBS influences the vasodilatory responses to hypoxia in neonatal cerebellar slices from HO-2-null (7) and CBSnull (41) mice ( Fig. 3 A and B) . Decreasing the O 2 concentration of the superfusate elicited a time-dependent arteriolar dilation, with a maximal dilation of 64% ± 8% within 10 min in WT mice (Fig.  3B ). The extent of the vasodilation was reduced by >50% in slices prepared from both HO-2-null mice (20% ± 3%) and CBS-null mice (31% ± 8%) (Fig. 3B) . The decreased vasodilation seen in CBS-null mice supports the notion that H 2 S is a physiological vasodilator that mediates responses to hypoxia. It might seem paradoxical that the loss of the vasoconstrictor HO-2/CO leads to decreased arteriolar vasodilation; however, note that in our model, hypoxia acts by inhibiting HO-2-derived CO generation, that is, by relieving the HO-2/CO vasoconstrictor tone. Thus, in HO-2-null mice, there is no longer any HO-2, and hence no HO-2/CO vasoconstrictor tone to be affected by hypoxia.
We substantiated the regulation of HO-2 by O 2 by measuring the endogenous CO concentration in cerebellar slices exposed to various O 2 concentrations (Fig. 3C) . In slices from WT mice, lowering O 2 from 10% to 1% decreased the endogenous CO concentration by 60% (Fig. 3D ). HO-2 deletion abolished the O 2 -dependent reduction in CO generation (Fig. 3D) . Moreover, quantitative measurements of H 2 S by bimane-assisted MS analyses (Fig. S4) revealed that hypoxia caused a significant elevation of endogenous H 2 S in WT mice, but not in HO-2-null mice (Fig. 3E) . Under normoxia, H 2 S levels were similar in WT and HO-2-null mice, presumably due to compensation from other sources of H 2 S in the transsulfuration pathway (27) . In addition, CORM-2 inhibited H 2 S production in WT whole-brain lysates in a concentration-dependent fashion (Fig. S5A) , and CO gas similarly inhibited H 2 S production in WT whole-brain homogenates (Fig.  S5B) . These data indicate a role for the HO-2/CO system in the hypoxia-induced elevation of H 2 S in the brain.
Further evidence that HO-2 functions as an O 2 sensor comes from our finding of a K m value of ∼15 μM (∼11 mm Hg) of recombinant mouse HO-2 for O 2 in vitro (Fig. S5C )-a suitable K m value for an O 2 sensor to detect and respond to changes in the brain tissue O 2 concentration (42). Although isoenzyme HO-1 is expressed in nucleolar-like structures in nuclei, no immunoreactivity for bilirubin-IXα (43), a byproduct of HO-catalyzed reactions, was detected, suggesting that CO is not produced in the nucleus by HO-1 ( Fig. S6 A and B) . Thus, it is unlikely that HO-1 participates in this system. These data indicate that HO-2 is the O 2 sensor in the brain that mediates the vascular responses to hypoxia.
Hypoxia-Induced Vasodilation of Precapillary Arterioles in Vivo Is
Attenuated in HO-2-Null Mice and Abolished in CBS-Null Mice. Although the cerebellar slice preparation provides refined experimental conditions ex vivo, it cannot adequately mimic the complex O 2 gradient geometry in a living organ, that is, the O 2 gradient profile along various segments of the microvascular tree and in the radial direction in tissues. To circumvent such ambiguity inherent in ex vivo systems, we used an intact live-mouse model in which cerebral blood vessels are visualized by two-photon imaging of the cerebral cortex in adult mice through a closed thinned-skull window (44, 45). This approach allowed us to maintain the physiological local concentrations of various gases. The neuro-gliavascular unit in the adult cerebral cortex, similar to the neonatal cerebellum ( Fig. 1) , displays HO-2 in neurons and endothelium and CBS in glia ( Fig. S6 C and D) . To ascertain whether HO-2 and CBS contribute to the hypoxia-induced microvascular responses in vivo, we ventilated anesthetized mice first with normal air (21% O 2 ) and then with 10% O 2 (Fig. 4) . We examined hypoxic responses of small arterioles at an ∼100-μm depth in the cortex under controlled conditions (Fig. S7) . Cerebral arteries penetrate from the surface into deeper layers, becoming diving (penetrating) arterioles, which lead to the smallest precapillary arterioles. In WT mice, reduction in inhaled O 2 caused an immediate and robust dilation of both diving and precapillary arterioles (Fig. 4C) . The magnitude of the hypoxia-induced precapillary arteriolar vasodilation was severely attenuated in HO-2-null mice (Fig. 4C ). These results suggest that different mechanisms mediate the hypoxic vasodilatory responses at different points in the hierarchy of the microvasculature, even within consecutive arteriolar segments. In proximal arterioles, close to arteries, tissue O 2 concentrations are higher and decrease more slowly during hypoxia compared with (Figs. 2 and 3 A and B) , we used CBS-null mice on a C57BL/6J background, given that survival past weaning was not critical. We presumed that the difference in background of the two mouse strains does not influence the CO/H 2 S dynamics. We found that the hypoxia-induced precapillary arteriolar vasodilatory response was abolished in CBS-null mice, but not in CSEnull mice (48) (Fig. 4F ), indicating that CBS-derived H 2 S, but not CSE-derived H 2 S, mediates this vasodilatory response. This finding is in agreement with the lack of CSE's endothelial localization in the brain (Fig. S2) , in contrast to its localization to endothelium in peripheral blood vessels (18) .
Impaired Ability of HO-2-Null Mice to Maintain ATP Levels on Hypoxia. We found that hypoxia-induced precapillary arteriolar dilation was impaired by 50% in HO-2-null mice (Fig. 4C ). To examine whether such a compromised microvascular response to hypoxia might lead to impaired energy metabolism, we monitored ATP and its degradation metabolites, ADP and AMP, using CE-MS in the whole brain of WT and HO-2-null mice after 1 min of hypoxia (10% O 2 ) (Fig. 5A ). Hypoxia resulted in elevated concentrations of AMP, and to a lesser extent of ADP, in both WT and HO-2-null mice. However, with hypoxia, ATP levels declined by 50% in the HO-2-null mice, but remained unchanged in the WT mice. As a result, energy charge values on hypoxia were unchanged in the WT mice, but dropped to <0.5 in the HO-2-null mice. These data indicate that impaired energy metabolism ensues from impairment of the microvascular responses to hypoxia in HO-2-null mice.
Glucose consumption varies regionally in the brain, with higher levels in the cerebral cortex compared with the hippocampus (49). Because these two regions comparably express HO-2 (6, 14), we examined regional variation in hypoxic responses using semiquantitative imaging mass spectrometry (IMS) (Fig. 5 B and C) . Under normoxia, cortical ATP levels were higher in HO-2-null mice than in WT mice. After exposure to hypoxia (10% O 2 ) for 1 min, cortical and hippocampal ATP levels remained unchanged in the WT mice but decreased by 50% in the HO-2-null mice. These findings indicate that the HO-2/CO system is a determinant of basal energy metabolism and its tolerance to hypoxia in these regions.
Discussion
In the present study, we have demonstrated major roles for HO-2 and CBS, forming CO and H 2 S, respectively, in regulating the cerebral microvascular response to hypoxia. We have substantiated these findings both in cerebellar slices and in the cerebral cortex of live mice. We have shown that H 2 S, formed by CBS, is critical to the hypoxic responses of the cerebral microcirculation, which are abolished in intact CBS-null mice.
The existence of a CO-dependent vasoconstrictor tone is established by the substantial arteriolar vasodilation elicited by HO inhibitors, as well as by the elevated basal ATP levels in the brains of HO-2-null mice. Despite the loss of vasoconstrictor tone with HO-2 deletion, the absence of the enzyme eliminates the proposed mechanism for hypoxia-induced vasodilation, namely inhibition of HO-2 with consequent activation of CBS to generate vasodilatory H 2 S (17-21). Accordingly, in HO-2-null mice, hypoxia fails to induce arteriolar dilation. Moreover, our sensitive analytic methodology establishes that endogenous CO levels (several of which are micromolar) are sufficient to inhibit CBS by binding its ferrous heme in vivo (27) . The direct inhibition of CBS activity by CO donor and CO gas ( Fig. S5 A and B) supports the physiological interplay of CO and H 2 S. However, caution must be used in extrapolating these in vitro data to in vivo physiology. In vivo relevance for the postulated CO-H 2 S link is afforded by our experiments showing that the hypoxia-induced increase in brain H 2 S is abolished in HO-2-null mice (Fig. 3E) .
The localization of HO-2 and CBS supports these physiological interactions. CBS is localized exclusively to astrocytes, including the Bergmann glia of the cerebellum. Astrocytes are well disposed to influence blood vessels, given their prominent endfeet that contact the vessels directly. Astrocytes also can transduce information from neurons to blood vessels, because they typically ensheath synapses. HO-2 is localized to both neurons and blood vessel endothelium, confirming previously reported findings in the brain (6, 14) and peripheral tissues (7, 9) . Because hypoxia affects all cells in the brain, ascertaining whether the physiological influence of CO on CBS involves neuronal or endothelial HO-2 is difficult. In either instance, we presume that CO diffuses into the astrocytes containing CBS.
Our measurements of vasodilation have focused on arterioles, which are classically considered the primary regulators of the cerebral circulation, given that capillaries do not contain smooth muscle. However, capillaries are surrounded by pericytes, cells with contractile properties that can regulate capillary blood flow (36). Astrocytes form intimate connections with pericytes (1, 2). Thus, it is possible that astrocytic H 2 S diffuses to pericytes to alter their contractile activity, thereby influencing capillary blood flow.
How does regulation of the cerebral circulation by H 2 S and CO interact with the effects of other neurotransmitters and neuromodulators? H 2 S appears to be a physiological mediator of hypoxia-induced precapillary arteriolar vasodilation, which is virtually abolished in CBS-null mice. Functional hyperemia is largely determined by nNOS, with a 50% reduction seen in rats treated with nNOS inhibitors (5). However, NO does not appear to play a significant role in the cerebral vasodilation elicited by hypoxia; in most studies, NOS inhibitors were found to not attenuate this vasodilation, although reductions were seen in some studies (50). Functional hyperemia also involves the arachidonic acid pathway (5), which might be modulated by endogenous CO (34, 51). Thus, glutamate acting on metabotropic receptors on astrocytes stimulates the formation of arachidonic acid, which gives rise to a variety of eicosanoids, some vasoconstricting and some vasodilating (2) . Accordingly, agents that affect the eicosanoids elicit variable effects on the cerebral circulation.
Although numerous mediators appear to be involved in the regulation of vascular tone at different points in the hierarchy of the cerebral microvasculature, our findings in the present study provide evidence suggesting that HO-2 generates CO in an O 2 -dependent manner and reserves the capacity to dilate precapillary arterioles during hypoxia through a mechanism involving theability of the gas to inhibit the CBS/H 2 S system. On hypoxia, the mechanism is unlocked through a fall in CO that triggers the microvascular dilation. Lack of such an adaptive vascular response in HO-2-null mice compromises the brain's ability to maintain ATP levels and the energy charge. In these mice, the failure to maintain the local ATP concentration on hypoxia appears to result from impaired hypoxia-induced arteriolar vasodilation; however, our investigations using semiquantitative IMS combined with CE-MS suggest that targeted deletion of HO-2 in the brain leads to the lack of a "respiratory lock" by the constitutive CO, resulting in the surprising elevation of the basal ATP concentration observed in the cerebral cortex and hippocampus. That is, CO modestly suppresses ATP production under normoxia, but once this tonic inhibition is eliminated on hypoxia, it gives way to the rise in dynamic strength of compensatory ATP maintenance.
In HO-2-null mice, neurovascular units lacking the lock are unable to immediately enhance further respiration to salvage ATP. This notion is consistent with previous studies indicating that pharmacologic inhibition of HO increases basal O 2 consumption in the liver (52) and that an increase in endogenous CO, by enzyme induction inhibits cellular respiration through its inhibitory effect on cytochrome c oxidase (53). H 2 S also might modulate mitochondrial respiration through reversible inhibition of cytochrome c oxidase (54); however, at least in the present study, basal H 2 S levels in the brain are unchanged in HO-2-null mice compared with WT mice (Fig. 3E) , possibly due to compensatory changes in endogenous H 2 S production from other enzymes in the transsulfuration pathway (27) . Although our findings provide evidence for a unique protective mechanism in the neurovascular units against hypoxia through the coordinate actions of two gaseous mediators, further investigation is needed to reveal functional links between neuronal and microvascular coupling through gas-responsive metabolic systems.
Materials and Methods
Animals. See Table S1 for primers used in genotyping.
Immunohistochemistry. Table S2 summarizes the antibodies used.
Cerebellar Slice Preparation and Arteriolar Diameter Measurements. Transverse slices (400 μm thick) of the cerebellar vermis from 9-to 15 d-old male mice were prepared using a vibratome (Leica VT1000S), as described previously (55, 56). 
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Animals. This study used four mouse strains: HO-2 null (1), cystathionine β-synthase (CBS) null (2), cystathionine γ-lyase (CSE) null (3) on the C57BL/6J background, and CBS null on the C3H/ HeJ background (4). Mice heterozygous for the disruption in each gene were bred at Keio University School of Medicine and fed ad libitum a standard CE-2 diet (CLEA Japan). Genotypes were verified by PCR of tail genomic DNA. Table S1 lists the primers used for genotyping. All of the mice used in this study were male. All experimental protocols were conducted in accordance with the institutional guidelines provided by the Keio University School of Medicine's Animal Care Committee.
Immunohistochemistry. The specimens were fixed in paraformaldehyde-lysine-periodate solution at 4°C for 4 h, cryoprotected, and then embedded in the optimal cutting temperature compound (Miles Laboratories). Coronal sections (60-μm thick) were prepared at −20°C. Sections were dried, permeabilized in PBS containing 0.3% Triton X-100, and then incubated in 5% normal serum in PBS containing 0.3% Triton X-100 and 0.2% BSA for 1 h at room temperature to block nonspecific antibody binding. Sections were incubated with the optimal concentration of antibodies (Table S2 ). Specimens were examined with an Olympus Fluoview 1000 laser scanning microscope.
Western Blot Analysis. Tissues were homogenized in ice-cold cell lysis buffer (Cell Signaling). In brief, 30-40 -μg of total proteins was diluted in Laemmli buffer containing 5% β-mercaptoethanol, denatured for 5 min at 95°C, separated by SDS/PAGE (10% gels), and transferred onto PVDF membranes. The membranes were treated in PBS with 0.05% Tween 20 and 3% nonfat milk for 1 h, and then incubated overnight at 4°C with antibodies against HO-1 (OSA110, 1:1,000; Stressgen), HO-2 (OSA200, 1:5,000; Stressgen), CBS (5) (1:2,500; a gift from Drs. Tsuneo Omura and Masao Sakaguchi, University of Hyogo, Hyogo, Japan), and CSE (6) (1:10,000). The membranes were then rinsed with PBS containing Tween 20 and incubated with the appropriate HRP-conjugated secondary antibody for 1 h at room temperature. Proteins were detected with ECL reagent on an X-ray film.
Cerebellar Slice Preparation and Arteriolar Diameter Measurements.
Transverse slices (400 μm thick) of the cerebellar vermis from 9-to 15-d-old male mice were prepared using a Leica VT1000S vibratome, as described previously (7, 8) . Slices were incubated for 1-2 h in artificial cerebrospinal fluid (ACSF) containing 124 mM NaCl, 26 nM NaHCO 3 , 1 nM NaH 2 PO 4 , 2.5 mM KCl, 1.8 mM CaCl 2 , 2 mM MgCl 2 , and 10 mM D-glucose (pH 7.4) in a static bath chamber, saturated with 95% O 2 and 5% CO 2 kept at 33-35°C. Hypoxia was simulated in ACSF by bubbling 95% N 2 /5% CO 2 . Blood vessels were visualized with an upright microscope equipped with a differential interference contrast and a CCD camera (Hamamatsu Photonics C-3077-78). We selected vessels with >50 μm of their length in focus from the molecular and Purkinje layers. These vessels were pretreated with thromboxane A 2 receptor agonist 9,11-dideoxy-11α,9α-epoxymethanoprostaglandin F 2α (U46619, 3 nM; Calbiochem). To examine the actions of carbon monoxide, tricarbonyldichlororuthenium(II) dimer (Sigma-Aldrich), [Ru(CO) 3 Cl 2 ] 2 , a CO-releasing molecule (CORM-2, 100 μM) (9), was freshly prepared and superfused. Stock solutions of zinc protoporphyrin-IX (Frontier Scientific) and chromium (III) mesoporphyrin-IX (CrMP; Frontier Scientific) were prepared in 0.1 M NaOH and diluted to the desired concentration in ACSF.
Acquired images were analyzed using MetaMorph image software (Molecular Devices). Intraluminal diameters are the mean values of 5-10 measurements taken every 4-5 μm along the vessel.
Determination of CO Concentration. The CO concentration of cerebellar slices was assayed as described previously (10), with several modifications. Slices were incubated in ACSF saturated with varying concentrations of O 2 for 90 min at 37°C. Tissues were then placed in four volumes of ice-cold water in 2-mL polypropylene tubes and sonicated on ice using a Branson 250 sonifier with a 1.3-mm diameter microtip probe (for 0.5-to 1.5-mL volumes) operated at a setting of 50% output power (10 W) until the suspensions became completely homogenous (<15 s). The tubes with 20% wt/wt sonicates were sealed and immediately analyzed for CO concentration. For this, 5 μL of 30% sulfosalicylic acid was pipetted into triplicate glass vials placed in a polypropylene rack in icy water. Water was added to reach a final reaction volume of 60 μL (including tissue sonicates). Two sets of triplicate blank vials with 55 μL of water were prepared as well. All vials were sealed with septum-containing screw caps. The vial headspace was then purged for 2 s with CO-free air at a flow rate of 500 mL min . Sonicates (40 μL) were injected into the liquid layer of each vial, which was vigorously shaken before incubation at 25°C for 30 min. The vial caps were covered with ice, and the vial headspace was analyzed as soon as possible after incubation to keep CO from bleeding through the septum. CO liberated from the sonicates and released into the vial headspace during the incubation period was quantified by gas chromatography (Shimadzu GC-14B, molecular sieve 5A 60/80 column attached to a methanizer). One set of the triplicate blank vials was analyzed both before and after analysis of the tissue samples. The mean CO concentration of the blank vials (usually <5 pmol) was subtracted from the CO measured in the tissue sample vials. Tissue CO concentrations are expressed as pmol of CO/mg of tissue.
Determination of Endogenous H 2 S Concentration in Neonatal Mouse
Brain. To measure the endogenous H 2 S concentration of brain tissues, we used the thiol-specific derivatization agent monobromobimane (11-13), followed by mass spectrometry. Whole bodies of 12-d-old mice were rapidly frozen in liquid nitrogen in a glove anaerobic workstation (Invivo 300; Ruskinn Technology). Frozen brains were dissected with a surgical knife at −20°C. Each brain (∼200 mg) was placed in two volumes of ice-cold 5 mM monobromobimane (Invitrogen) in 10 mM Tris-HCl (pH 7.5) in 2-mL polypropylene tubes, homogenized at 4°C with 3.0-mm zirconium beads using MicroSmash (Tomy Seiko), and then incubated for 10 min on ice. Methanol (10% vol/vol) was added to precipitate proteins. The mixture was vortexed and then centrifuged for 15 min at 20,400 × g. The supernatant was desalted through a column containing polymeric water-wettable reversedphase sorbent (Oasis HLB cartridge, WAT200677; Waters), and filtered through a centrifugal filter (Millipore Ultra free-MC; 5-kDa cutoff). Aliquots of 10 μL were analyzed to quantify sulfide dibimane (SDB) through liquid chromatography-electrospray ionization-tandem mass spectroscopy (LC/ESI/MS/MS). This method allowed us to determine the endogenous H 2 S concentration in frozen brain samples without the addition of CBS or CSE substrate excess.
LC/ESI/MS/MS experiments were performed by sensitive LC-MS (Shimadzu LCMS-8030 triple-quadrupole mass spectrometer coupled to a Shimadzu Nexera UHPLC system). Chromatography was conducted on a Waters Acquity CSHTM C18 HPLC column (1.7 μm, 2.1 × 150 mm) at a flow rate of 0.2 mL/min. The mobile phase consisted of (A) 0.1% formic acid in water and (B) 0.1% formic acid in acetonitrile using a gradient elution of 0 min, 2% B; 5 min, 2% B; 23 min, 50% B; 25 min, 100% B; 27 min, 100% B; 28 min, 2% B; and 30 min, 2% B. The column oven was maintained at 40°C. The column effluent was introduced into the mass spectrometer using an electrospray ionization (ESI) interface operating in the negative-ion mode. The source temperature was set at 400°C, and the ion spray voltage was set at 4.5 kV. Nitrogen was used as a nebulizer and drying gas. The tandem mass spectrometer was tuned in the multiple reaction monitoring mode (MRM) to monitor mass transitions m/z Q1/Q3 413.10/191.20 (SDB). The optimized MS/MS operating parameters used for SDB were a 100-ms dwell time, −20 V declustering potential, −20 V collision energy, and −20 V cell exit potential. The autosampler temperature was set at 4°C.
H 2 S Production Assays. The enzymatic capacity for H 2 S production in mouse cerebellum, mouse whole brain, and cultured cerebellar astrocytes from WT and CBS-null mice was measured as described previously (14, 15) . The mouse cerebellum (12% wt/vol) or whole brain (10% vol/vol) was homogenized in ice-cold 50 mM PBS (pH 8.0) with a polytron homogenizer. Primary astrocytes were sonicated in ice-cold 50 mM PBS (pH 8.0). The reactions were performed in 25-mL (10-mL in the case of the mouse whole brain homogenates) Erlenmeyer flasks fitted with septum stoppers and center wells. A 2-mL tube containing a piece of filter paper (0.5 × 1.5 cm) soaked with zinc acetate (1%; 0.3 mL) was placed inside the center well. The reaction mixture contained 10 mM L-cysteine, 10 mM DL-homocysteine, and 2 mM pyridoxal 5′-phosphate in 0.45 mL of homogenates. To measure CBS-dependent H 2 S production, the flasks were flushed with a slow stream of nitrogen or pure CO gas for 30 s and then sealed with airtight serum caps. The flasks were then transferred to a 37°C shaking water bath. After 90 min (30 min in the case of mouse whole brain homogenates), trichloroacetic acid (50%; 0.5 mL) was injected into the reaction mixture through the serum caps. Another 60 min was allowed for the complete trapping of the evolved H 2 S by the zinc acetate solution to form zinc sulfide. Then the serum cap was removed, and N,N-dimethyl-p-phenylenediamine sulfate (20 mM; 50 μL) in 7.2 mM HCl and FeCl 3 (30 mM; 50 μL) in 1.2 mM HCl were added to the 2-mL tube in the center well. After 20 min, absorbance at 670 nm was measured with a microplate reader. The calibration curve of absorbance versus H 2 S concentration was obtained using NaHS solutions of varying concentrations as standards. When NaHS is dissolved in water, HS − is released and forms H 2 S with H + . The H 2 S concentration was assumed to be 30% of the original NaHS concentration. The calibration curve was linear from 0 to 320 μM NaHS or 96 μM H 2 S.
For the effect of CORM-2 (9) on H 2 S production in whole brain lysates, the foregoing protocol above was modified as follows. In brief, the mouse whole brain was lysed in ice-cold 100 mM potassium phosphate buffer (pH 7.4), 10 times the weight, for 5 min using a tissue grinder. The lysates were then sonicated on ice for four 10-s pulses, with a 10-s break between each pulse. The sonicated lysates were spun down at 13,200 × g for 30 min at 4°C. Only the supernatant was used in subsequent steps. Pyridoxal 5′-phosphate, L-cysteine hydrochloride, DL-homocysteine, and CORM-2 were added to the supernatant to make the final reaction solution (50 μM pyridoxal 5′-phosphate, 10-mM L-cysteine hydrochloride, 10 mM DL-homocysteine, and varying CORM-2 concentrations). The reactions were performed in a specially designed 96-well plate, with each well divided into an outer compartment and an inner compartment. Once the plate was sealed airtight, the outer and inner compartments in each well were still continuous above. ), tracheotomized, and intubated with a handmade Y-shaped tube for mechanical ventilation. The left femoral artery was cannulated for sampling arterial blood for blood gas analysis. In some experiments, an arterial catheter connected to a pressure transducer (MP 150; BioPac Systems) was placed in the left femoral artery to continuously monitor mean arterial pressure (sampling rate, 100 Hz). Rectal temperature was maintained at 37.0 ± 0.5°C throughout the experiment with a custom-made heating pad.
Skull thinning was performed as described previously (17, 18) . In brief, after creation of a ring-shaped well, the bone was thinned to ∼50 μm using a high-speed drill (Volvere V max ; NSK Nakanishi) at a speed of 5,000 rpm. During the drilling process, the skull was cooled with saline solution to prevent damage caused by heating the surface of the brain. After creation of the window, animals were mechanically ventilated with a small-animal ventilator (MiniVent type 845; Harvard Apparatus) with 21% O 2 , balanced by N 2 , at a tidal volume of 8 μL g −1 with a respiratory rate of 120 breaths min
. A 30-min period was allowed for breathing to stabilize. The animal was then challenged for 30 min with 10% O 2 balanced with N 2 (hypoxia). A small aliquot of arterial blood (∼70 μL) was sampled before and after the 30 min of hypoxia and analyzed with a blood gas analyzer (model 300F; i-STAT). Basal values of arterial partial pressures of O 2 (pO 2 ) and CO 2 (pCO 2 ) and arterial blood pH were within the normal ranges reported in the literature (19, 20) (Fig. S7) . Animals with basal values of >40 mm Hg pCO 2 , <25 mm Hg pCO 2 , or <70 mm Hg pO 2 were excluded from the analysis. Thus, our procedure did not alter blood pO 2 levels. Because the brain pO 2 is generally in equilibrium with the blood pO 2 , we presumed that the procedures did not elicit any marked alterations.
The two-photon microscope consisted of a custom-made upright microscope (BX61WI; Olympus) attached to a mode-locked titanium-sapphire laser system (Chameleon Vision II; Coherent) that could achieve a 140-fs pulse width and an 80-MHz repetition rate, with 17 W of pump power and an 800-nm laser. Images (512 × 512 pixels) were acquired with an Olympus FV1000 scanning unit using Fluoview software (version FV10-ASW; Olympus) and a 25× objective (XLPLN25 × WMP; NA 1.05). The maximum average power exiting the objective lens was reduced using an acoustooptical tunable filter by tuning a transmissivity parameter in the Fluoview software. Emitted fluorescence was detected with an external photomultiplier tube (R3896; Hamamatsu Photonics) after passing through an infrared-blocking filter (685-nm cutoff) and an emission filter (420-520 nm). When necessary, a spectral scan of the emitted fluorescence was conducted at increments as small as 5 nm, using a spectral detection system with the FV1000 scanner. To visualize the cerebral microvasculature, a small bolus (∼15 μL) of Q-dot 655 nanocrystals (Q21021MP; Invitrogen) was injected and detected with a 641-nm emission filter with a 75-nm bandwidth. To differentiate arterioles from venules, rapid image (256 × 256 pixels) scanning, at a scan speed of 2 pixels μs −1 (0.429 image s ) was performed for 30 s during dye injection. The time to the appearance of the dye was then analyzed to identify arterioles. With the thinned-skull preparation, we were able to visualize vasculature in the cortex up to ∼400-μm deep.
To examine changes in the arteriolar diameter in response to hypoxia, we collected images (512 × 512 pixels) at a scan speed of 10 pixel μs −1 every 1 min during the first 10 min and then every 5 min thereafter. Acquired images were processed with an 8-bit digitizer, and the pixel-based data (0.497 μm pixel −1 ) were converted to a gray scale by the digital imaging software (MetaMorph 6.1; Universal Imaging). Pixel-by-pixel gray density was measured as radial line scans including a part of the region outside each vessel at the longest distance of the ellipsoidal shape of the cross-sectional area of a diving (penetrating) arteriole, and perpendicular to the longitudinal axis of a precapillary arteriole. We defined a pixel with >70% of the maximum gray density as intravascular.
Imaging Mass Spectrometry. Imaging mass spectrometry was performed as described previously (21) . The brain is extremely susceptible to postmortem changes in the concentration of labile metabolites, such as adenylates. To trap the metabolites as they exist in vivo and minimize autolytic changes, we used the in situ freezing method (22, 23) , which enables the suspension of metabolic processes by rapidly lowering the tissue temperature while maintaining blood flow and oxygenation during the freezing process. In this procedure, mice were deeply anesthetized with diethyl ether, and the head skin was trimmed. The head was then dipped into liquid nitrogen in such a way to avoid immersing the nose. Frozen brains were dissected with a surgical knife in a refrigerated box at −20°C. Serial coronal sections (10 μm thick) were cut with a cryomicrotome (CM1900; Leica) and thaw-mounted on an indium tin oxide-coated glass slide (578274; Sigma-Aldrich) at −20°C. Before matrix deposition, tissue slices were kept for 20 min with desiccant to equilibrate with the room temperature and then for another 20 min in a vacuum chamber; this dehydration process prevented the specimens from detaching during MALDI-TOF experiments, which were performed under complete vacuum. Glass slides were mounted onto an MS target plate (Shimadzu) with conductive-adhesive double-sided tape (3M). Microdeposition (pL level) of the matrix solution on the tissue specimens was conducted using an automatic chemical inkjet printer (CHIP-1000; Shimadzu), using freshly prepared 25 mM 9-aminoacridine in 70% (vol/vol) methanol. As an external standard for calibration, a 0.5-μL aliquot of 100 μM angiotensin II in distilled water was spotted near the specimen, and the same volume of the matrix was mixed with the standard on the glass slide. A 200-pL aliquot of 9-aminoacridine was deposited on each spot at a pitch of 0.2 mm on the specimen. This process was repeated 25 times. After matrix deposition, the slides were kept in a vacuum chamber for 20 min to allow the matrix to dry. Images were typically collected from 53 × 35 spots (a total of 1,855 spots) separated by a 0.2-mm pitch, for an image size of 10.6 mm × 7.0 mm. MALDI mass spectra were acquired using an AXIMA Performance system (Shimadzu) with a 337-nm nitrogen laser (10 Hz), operating in the linear negative mode. Unless noted otherwise, mass spectra were obtained with an accelerating voltage of 20 kV, a scanning mass range of 1-2,000 Da, and "pulsed extraction mass" set to 1,000 Da. The mass spectrometer was calibrated with spotted angiotensin II and 9-aminoacridine, which had a mass-to-charge ratio (m/z) of 1,044.52 and 193.07, respectively, in the negative mode. In parallel, the laser power was optimized to obtain a high ratio of standard to matrix. The irradiation area was determined based on the positional information obtained from the CHIP-1000 with minor adjustments. All imaging data were acquired under vacuum (8.0 × 10 −5 Pa). The part of the spectrum under m/z 250 was not collected, because several major peaks from 9-aminoacridine were obtained under m/z 250 Da in the negative mode, which reduced the sensitivity of the target mass range. The number of laser shots per spot was set to 200 with a roaming function that allowed the device to obtain averaged data from each spot, thereby avoiding the effects of a spotty matrix.
The standards for tandem MS were produced by mixing 1 μL of the diluted 1 μM standard solution with 1 μL of 25 mM 9-aminoacridine in 70% methanol for each standard. For crystalline matrices, the samples were allowed to air-dry at room temperature. BioMap software (Novartis; www.maldi-msi.org) was used to reconstruct the image. The 9-aminoacridine was obtained from Kanto Chemical, and all other chemicals were obtained from either Sigma-Aldrich or Wako. All chemicals were of analytical or reagent grade.
Metabolic Mapping. To construct metabolic maps, mass signals covering m/z values of 250-2,000 were collected from 53 × 35 spots from the tissue slice. Direct comparison between metabolite maps of different slices require a realistic transformation of the acquired mass signals of a metabolite into absolute units, such as μmol/g. To do this, we estimated the apparent concentration of a specific metabolite at the ith spot of tissue (C i ) as follows:
where C′, denotes the metabolite concentration of tissue from a contralateral hemisphere determined by capillary electrophoresis-electrospray ionization mass spectrometry (CE/ESI/MS), I i is the maximum intensity among mass spectra in a specified range at the ith spot, and I is the median of maximum intensities of a metabolite from all of the spots in the contralateral hemisphere.
To construct an ion-concentration map, data acquired with the AXIMA Performance MALDI mass spectrometer were saved as 1,855 comma-separated variable (CSV) files, with each file containing m/z values between 250 and 2,000 and their corresponding values of mass intensities as single-spot information. These 1,855 CSV files were automatically read, compiled as a single file, and processed to construct an ion-concentration map. All of the transformation processes were automated by a custom script written in Python; for instance, to map ATP concentration of a brain section, a maximum intensity in the m/z regions between 505.5 and 506.5 with a pitch of 0.03368 was chosen, normalized, and converted to an apparent tissue concentration of ATP ([ATP] app in μmol/g tissue ) using Eq. S1. The [ATP] app calculated from 1,855 spots was then automatically registered to appropriate x-y coordinates. The resulting CSV file was finally exported to Microsoft Excel, and the values of [ATP] app were color-coded on the appropriate x-y coordinates.
Conversions using Eq. S1 assume that MS intensities are linearly correlated with the concentration of a metabolite. Under the specified conditions in vitro using various concentrations of each adenylate, the concentration is empirically a linear function of the height of the mass signal; thus, we assumed that this relation holds true in the tissue specimens as well.
Three regions of interest were selected by careful visual inspection to match the anatomic localization delineated by the H&E staining of identical specimens. Extracted values within each region of interest were averaged and used for the assessment of region-specific analysis of changes in each metabolite and energy charge in the hypoxic brain. Identical areas from the contralateral hemispheres were examined as controls.
Quantification of Metabolites by CE/ESI/MS. CE/ESI/MS analysis was performed as described previously (21, 24) . CE/ESI/MS is unique in that it allows high-throughput analysis of water-soluble metabolites from biological samples. All CE/ESI/MS experiments were performed using an Agilent CE capillary electrophoresis system equipped with an air pressure pump, an Agilent 1200 series Mass Selective Detector (MSD) mass spectrometer, an Agilent 1200 series isocratic HPLC pump, an Agilent G1603A CE/MS adapter kit, and an Agilent G1607A CE/MS sprayer kit. System control, data acquisition, and MSD data evaluation were performed using Agilent G2201AA ChemStation software for CE-MSD.
Frozen brain sections were immediately plunged into ice-cold methanol (500 μL) containing internal standards (300 μM each of L-methionine sulfone for cations and Mes for anions) and homogenized with a polytron homogenizer (Ultra-Turrax T25; IKA Laborteknik) at 8,000 rpm for 1 min to inactivate enzymes. Then 250 μL of ultrapure water (LC/MS grade; Wako) was added, 750 μL of the solution was transferred, and 500 μL of chloroform was added, followed by thorough mixing. The resulting suspension was centrifuged at 15,000 × g for 15 min at 4°C. The upper aqueous layer was extracted again with chloroform and then centrifugally filtered through a 5-kDa cutoff filter (Millipore) to remove proteins. The filtrate was concentrated with a vacuum concentrator (SpeedVac; Thermo), and dissolved in 200 μL of ultrapure water containing reference compounds (200 μM each of 3-aminopyrrolidine and trimesate) before CE-MSD analysis.
All chemical standards were dissolved in ultrapure water, 0.1 N HCl, or 0.1 N NaOH to obtain 10 mM or 100 mM stock solutions. Working standard solutions were prepared by diluting stock solutions with ultrapure water just before CE-MSD injection.
For nucleotide-related metabolites, separations were carried out in fused-silica capillary tubes (50 μm inner diameter × 1 m total length) filled with 50 mM ammonium acetate solution (pH 7.5) as an electrolyte (25) . Before the first use, each new capillary was pretreated with preconditioning buffer (25 mM ammonium acetate/75 mM sodium phosphate solution; pH 7.5) for 20 min. Before each injection, the capillary was equilibrated by flushing with the preconditioning buffer for 10 min and then with the running buffer for 6 min, which was replenished every run using a buffer replenishment system equipped with the Agilent CE system. Sample solution was injected at 5 kPa for 30 s (∼30 nL). A voltage of 30 kV and a pressure of 5 kPa were applied to the inlet capillary during the run (25) . The capillary temperature was maintained at 20°C, and the sample tray was cooled to below 5°C. Ammonium acetate (5 mM) in 50% methanol/water (vol/vol) was delivered as the sheath liquid at 10 μL min −1
. ESI-quadrupole MS was operated in the negative-ion mode, and the capillary voltage was set at 3.5 kV. A flow of heated dry nitrogen gas (heater temperature 300°C) was switched off during the preconditioning step, and a pressure of 69 kPa was applied at 0.1 min after sample injection. Compounds were monitored using the selective ion monitoring (SIM) mode.
For cationic metabolites, a fused silica capillary tube (50 μm inner diameter × 1 m total length) was used for separation (26) . The electrolyte for CE separation was 1 M formic acid. Each new capillary was flushed successively with the running electrolyte for 20 min. Before each injection, the capillary was preconditioned for 5 min by flushing with the running electrolyte. Approximately 3 nL of sample solution was injected at 5 kPa for 3.0 s, with 30 kV of voltage applied. The capillary temperature was maintained at 20°C, and the sample tray was cooled to below 5°C. Methanolwater (50% vol/vol) containing 5 mM ammonium acetate was delivered as the sheath liquid at 10 μL min . ESI-MS was conducted in the positive-ion mode, and 4 kV of the ion spray voltage was applied after sample injection. A flow rate of heated dry nitrogen gas (heater temperature 300°C) was maintained at 69 kPa. For MS using the SIM mode, deprotonated [M+H] + ions were monitored for cationic metabolites of interest.
For anionic metabolites, a cationic polymer-coated COSMO (+) capillary tube (50 μm inner diameter × 1 m total length; Nacalai Tesque) was used for separation (27) . The electrolyte used for CE separation was 50 mM ammonium acetate solution (pH 8.5). Each new capillary was flushed successively with running buffer (50 mM ammonium acetate solution; pH 8.5), 50 mM acetic acid (pH 3.4), and then running buffer again, for 20 min each. In addition, before each injection, the capillary was flushed with 50 mM acetic acid (pH 3.4) for 2 min, followed by the running electrolyte for 5 min. Samples were injected at 5 kPa for 30 s (∼30 nL). The applied voltage was set at −30 kV. The capillary temperature was maintained at 20°C, and the sample tray was cooled to below 5°C. Methanol-water (50% vol/vol) containing 5 mM ammonium acetate was delivered as the sheath liquid at 10 μL min −1
. ESI-MS was conducted in the negative-ion mode, with the ion spray voltage set to 3.5 kV. A flow rate of heated dry nitrogen gas (heater temperature 300°C) was maintained at 69 kPa. For MS using the SIM mode, deprotonated [M-H] − ions were monitored for anionic metabolites of interest.
Cerebellar Astrocytic Cultures. The cerebellum was dissected from 2-d-old mice, and the meninges were carefully removed. Dissociation was accomplished by incubation in papain/Dnase, followed by trituration. The dissociated cells were washed, suspended in MEM with 10% FBS, and plated onto poly-L-lysine-coated tissue culture plates. The cells were used 25-30 d later in vitro.
Expression and Purification of Recombinant HO-1, HO-2, and Biliverdin
Reductase. cDNA clones of truncated HO-1 (1-789 bp) and HO-2 (1-876 bp), and full-length biliverdin reductase were amplified by PCR from a cDNA library obtained from C57BL/6J mouse liver. The following primers were used for truncated HO-1 and HO-2 and full-length biliverdin reductase: 5′-TTT TCA ATT CAT GGA GCG TCC ACA GCC CGA CAG-3′ and 5′-TTT TCT CGA GTT ATG AGC TAG TGC TGA TCT G-3′, 5′-TTT TGA GTT CAT GTC TTC AGA GGT GGA GAC CTC G-3′ and 5′-TTT TCT CGA GTT ACT TCC TCA GCA CAG CCA CGG TTG-3′, and 5′-TTT TCA TAT GAG TAC TGA GCC AAA GAG-3′ and 5′-TTT TCA GCT GTC ACT GCT TCC GGT GGC A-3′, respectively. The HO-1 and HO-2 cDNAs were inserted into Eco RI and Xho I sites of pGex6P-1 (GE Healthcare). Mouse biliverdin reductase cDNA was inserted into Nde I and Xho I sites of pET14b (Pharmacia).
Expression vectors for mouse HO-1 and HO-2 were transformed into BL21 (DE3), and the bacteria were incubated in LB with ampicillin at 37°C until an OD 600 of 0.8 was reached. Protein expression was then induced by 1 mM isopropyl β-D-1-thiogalactopyranoside for 4 h at 37°C. Cells were pelleted by centrifugation at 6,000 × g, washed twice with ice-cold PBS, and resuspended in lysis buffer (0.1% Nonidet P-40 PBS) by trituration. The suspensions were sonicated twice for 5 min at 4°C and then centrifuged at 20,000 × g for 30 min. The supernatant was filtrated using a 0.45-μm filter and then incubated with Glutathione Sepharose 4B medium (GE Healthcare) for 1 h at 4°C. The resin was then washed five times with lysis buffer, and the GST tag was cleaved by the addition of PreScission Protease (GE Healthcare) for 16 h at 4°C. Recovered proteins were dialyzed against 0.1 M potassium phosphate (pH 7.4) and stored at −80°C. Expression of mouse biliverdin reductase protein was performed in a similar manner to that of the HO enzymes. His-tagged biliverdin reductase was purified with Ni-NTA resin (Qiagen). Protein-bound resin was washed five times with wash buffer [20 mM phosphate (pH 7.4), 300 mM NaCl, 5 mM imidazole, and 0.1% Tween 20] and eluted with elution buffer [20 mM phosphate (pH 7.4), 300 mM NaCl, and 0.1% Tween 20] . The eluate was dialyzed against 0.1 M potassium phosphate (pH 7.4).
Estimation of K m for O 2 of Recombinant Murine HO-1 and HO-2. Apparent K m values for O 2 were determined by measuring the activities of recombinant mouse HO-1 and HO-2 under different O 2 concentrations. The initial reaction rates were determined from the rates of bilirubin formation at 25°C (9, 28, 29) . To do this, the reaction mixture (400 μL) containing 360 μM heme oxygenase, 100 μM biliverdin reductase, 180 nM human recombinant NADPH-cytochrome P450 reductase (Wako), 4.7 U catalase (Sigma-Aldrich), 15 μM BSA, and 10 μM hemin in 0.1 M Hepes buffer (pH 7.4) was placed into a sealed quartz cuvettete. The solution and the gas phase in the cuvettete were purged with the desired concentration of O 2 balanced with N 2 for 10 min at 25°C. Then the reaction was started by adding 40 μL of NADPH (200 μM in the final reaction mixture). Bilirubin formation was determined by monitoring the absorbance at 470-540 nm at 1-min intervals. An extinction coefficient of 43.5 mM
was used for absorption at 470 nm. Apparent values for V max and K m were derived by iterative curve fitting using the MichaelisMenten equation.
Statistics. All values presented in this paper are expressed as mean ± SEM unless noted otherwise. Differences between means were evaluated for significance, using ANOVA followed by Fisher's exact test for multiple comparisons. Differences with a P value < 0.05 were considered statistically significant. TTG CTG GCT TGG CTT ATA G  HO-2-R1 (WT, reverse)  TTC CGG TGT AGC TCC GTG GGG  HO-2-F2 (KO, forward) CAA GGT GAG ATG ACA GGA GAT C HO-2-R2 (KO, reverse)
GCT TGG GTG GAG AGG CTA TTC CBS-F (common, forward)
GAT TGC TTG CCT CCC TAC TG CBS-R1 (WT, reverse) AGC CAA CTT AGC CCT TAC CC CBS-R2 (KO, reverse)
CGT GCA ATC CAT CTT GTT CA CSE-F (common, forward) TGC CGA CCA ATA AGC AGG GC CSE-R1 (WT, reverse) CCG AGG ACT GGC CCG GGA AGT CSE-R2 (KO, reverse)
CCA GAC CGG CAA CGA AAA TCA 
